The Group

Here are the current members of both lab029 and lab033.  This was updated on the 9 July 2019.

If you are interested in joining the group, give Prof.  Anthony Burke a “shout”.. ( or a call at +351266745310. We look forward to speaking with you and perhaps applying for some national or EU (Marie Curie) funding.


Elisabete Carreiro  is a senior research associate and integrated member of the Centro de Química de Évora.  She has both a BSc (Chemistry) and a PhD (Chemistry, European) from the University of Évora (2010). She has also been a visiting researcher in the groups of Carmen Claver (Universitat Rovira i Virgili, Tarragona) and Dr. Olaf Walter KIT, Karlsruhe. She is currently developing new nucleoside analogues, and innovative ways of drug delivery of these compounds, and is also involved as a research leader in the project NAQUIBIO focused on the development of chitin-silver nanoparticles for wound healing in dogs. She is also involved with the University of Evora, spin-out, Chiratecnics (

Carolina Marques  is a senior research associate in the Burke group and integrated member of the Centro de Química de Évora.  She has a BSc (Chemistry), an MSc (Applied Chemistry) and a PhD (Chemistry) from the University of  Évora (2013). She has previously worked in the group of Carlos Afonso at IST, Lisbon.  She is currently developing new catalytic methods using metal based catalysts for the synthesis of small-molecules for neurodegenerative diseases. She was the recipient of the prize of best PhD in organic chemistry by the SPQ (Portuguese Chemical Society) in 2013. And has co-authored two Wiley-VCH books.

Amina Moutayakine is a joint PhD student with José Padrón from the Institute of Bioorganic Chemistry at the University of La Laguna, University of Tenerife. She is working on the synthesis of novel small molecules for neurodegenerative diseases, as well as developing chemocatalytic methods to enantiomerically pure amines.

Marina Costa  has a BSc in biochemistry and an MSc in Chemistry. She has previously worked as a research assistant in the project NAQUIBIO which is focused on the development of chitin-silver nano-particles for wound healing in dogs.

Ana Catarina Amorim  has both an MSc and BSc degree from the University of Évora.She has already worked on the synthesis of novel 1,2,3-triazoles using the Sharpless-Meldal method using enabling synthetic methods. For her MSc project in this group she is working on novel catalytic methods for accessing biologically active 1,4-dibenzodiazapines, which is an important area in this group, with potential commercial applications. She is currently developing novel amphipathic membranes based on non-toxic and biodegradable polymers for water capture applications.

Carlos Sousa   is a final year student (biochemistry course, University of Evora) who is working on the development of novel cholesterol probes for treating various illnesses, including cardiovascular diseases and Alzheimer’s disease.

Pedro Brandão  is a fourth year PhD student of the CATSUS PhD program, and is working under the supervision of Prof. Burke, Prof. Marta Pineiro (Chemistry dept, University of Coimbra) and Dr. Maxim Kuznetsov from the Centro Química Estrutural, IST, Lisbon. He has an MSc in Pharmaceutical sciences from the University of Porto. He is working on the development of novel oxindole-hybrids for medicinal purposes using catalytic Multi-component reactions. He is currently working in  the lab of Prof. Marta Pineiro.